Greg Cima's profile photo

Greg Cima

Illinois

Reporter at 360Dx

Reporter at GenomeWeb

Science and business reporter for 360Dx/GenomeWeb

Featured in: Favicon genomeweb.com Favicon 360dx.com Favicon geneticliteracyproject.org Favicon avma.org Favicon pantagraph.com Favicon drovers.com Favicon agjournalonline.com Favicon precisionmedicineonline.com Favicon precisiononcologynews.com Favicon avmajournals.avma.org

Articles

  • Siemens Healthineers Expecting up to €300M Tariff Hit in Near Term

    1 week ago | 360dx.com | Greg Cima

    Note: This story has been updated with comments from a conference call to discuss the firm's financial results. NEW YORK – Siemens Healthineers said Wednesday that it expects tariffs implemented by the Trump administration will reduce its second half adjusted earnings before interest and taxes by €200 million ($227 million) to €300 million and its fiscal year adjusted earnings per share by €.15, although the firm posted growth in its Q2 diagnostics business and total revenues.

  • UPDATE: Siemens Healthineers Expecting up to €300M Tariff Hit in Near Term

    1 week ago | 360dx.com | Greg Cima

    Note: This story has been updated with comments from a conference call to discuss the firm's financial results. NEW YORK – Siemens Healthineers said Wednesday that it expects tariffs implemented by the Trump administration will reduce its second half adjusted earnings before interest and taxes by €200 million ($227 million) to €300 million and its fiscal year adjusted earnings per share by €.15, although the firm posted growth in its Q2 diagnostics business and total revenues.

  • UPDATE: Siemens Healthineers Expects up to €300M Tariff Hit in Near Term as Fiscal Q2 Dx Revenues Rise 2 Percent

    1 week ago | 360dx.com | Greg Cima

    Note: This story has been updated with comments from a conference call to discuss the firm's financial results.

  • Hologic Expects up to $25M in Quarterly Tariff Costs, Additional Pain From 'Geopolitical Turmoil'

    1 week ago | genomeweb.com | Greg Cima

    NEW YORK – Hologic said on Thursday that it is trying to mitigate between $20 million and $25 million per quarter in tariff-related costs and forecast that its business in China, already small to start with, will further diminish during fiscal 2025. Additionally, the Trump administration's cuts to international aid have reduced the firm's revenues from HIV testing in Africa, and company officials said that they doubt the business will bounce back.

  • Mursla Bio Preparing to Launch Liver Cancer Test

    2 weeks ago | genomeweb.com | Greg Cima

    NEW YORK – With its combination immunoassay and qPCR blood test, Mursla Bio intends to identify liver cancers earlier by detecting microRNA targets within extracellular vesicles.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
72
Tweets
149
DMs Open
Yes
Greg Cima
Greg Cima @CimaGreg
21 Oct 22

RT @360DxNews: Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court. The firm alleges its competitors infringe its…

Greg Cima
Greg Cima @CimaGreg
23 Sep 22

RT @360DxNews: UPDATE: FDA Allowed Problematic COVID-19 Tests on the Market Due to Agency's EUA Approach, HHS OIG Finds. In a report releas…

Greg Cima
Greg Cima @CimaGreg
9 Sep 22

RT @360DxNews: Allergenis Seeks to Change Peanut Allergy Testing. Allergenis claims its assay results are more accurate than other first-li…